Astrana Health Q4 Earnings Exceed Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 02 2026
0mins
Should l Buy ASTH?
Source: seekingalpha
- Strong Earnings Report: Astrana Health reported a Q4 Non-GAAP EPS of $0.54, beating expectations by $0.21, which highlights the company's significant profitability improvement and boosts market confidence in its future growth.
- Revenue Growth: The company achieved Q4 revenue of $950.5 million, a 42.9% year-over-year increase, surpassing market expectations by $20.04 million, indicating strong competitive positioning and robust customer demand.
- Care Partners Performance: The Care Partners segment generated revenue of $892.5 million, up 38% from $647.7 million last year, reflecting the company's successful expansion in value-based care and effective strategic execution.
- Future Guidance: Astrana provided a positive outlook for 2026, projecting total revenue between $900 million and $1 billion and Adjusted EBITDA between $60 million and $70 million, demonstrating the company's optimistic view of future market conditions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ASTH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ASTH
Wall Street analysts forecast ASTH stock price to rise
8 Analyst Rating
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 31.500
Low
26.00
Averages
33.20
High
40.00
Current: 31.500
Low
26.00
Averages
33.20
High
40.00
About ASTH
Astrana Health, Inc. is a physician-centric, artificial intelligence (AI)-powered healthcare company focused on delivering patient-centered care. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. It supports more than 20,000 providers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Astrana Health to Participate in Upcoming Investor Conferences
- Investor Conference Participation: Astrana Health announced that its leadership will participate in upcoming investor conferences, aiming to enhance the company's visibility in the healthcare sector and attract potential investors, thereby driving future growth and development.
- Tech-Driven Healthcare Services: As a physician-centric, technology-enabled healthcare company, Astrana Health supports over 20,000 providers and 1.6 million patients through its proprietary technology platform and aligned provider networks, committed to delivering high-quality, value-based care that enhances patient experiences and outcomes.
- Scalable Care Infrastructure: By combining a scalable care delivery infrastructure, Astrana Health promotes the implementation of proactive and preventive care, aiming to improve patient outcomes and enhance provider well-being, thus creating greater value across the healthcare system.
- Patient-Centric Commitment: Astrana Health's mission is to build a better healthcare system that ensures all patients receive high-quality care through better experiences and outcomes, reflecting the company's strong commitment to patient-centered principles.
See More
Astrana Health to Participate in Upcoming Investor Conferences
- Investor Conference Schedule: Astrana Health is set to participate in the 25th Annual Needham Virtual Healthcare Conference from April 13-16, 2026, showcasing its innovations and technology in healthcare to attract investor interest.
- Global Healthcare Conference: The company will also attend the Bank of America Global Healthcare Conference in Las Vegas from May 12-14, 2026, with a fireside chat scheduled for May 12, aimed at enhancing its market visibility and investor confidence.
- Growth Stock Conference: Astrana will be present at the 46th Annual William Blair Growth Stock Conference in Chicago from June 2-4, 2026, featuring a fireside chat on June 3 to highlight its achievements and future vision in value-based care.
- Provider Network Expansion: Currently, Astrana Health supports over 20,000 providers and 1.6 million patients, focusing on delivering high-quality, patient-centered care through its unique technology platform and aligned provider networks, thereby improving patient experiences and outcomes.
See More
Astrana Health to Participate in Upcoming Investor Conferences
- Investor Conference Participation: Astrana Health is set to participate in upcoming investor conferences to showcase its innovations and technological capabilities in the healthcare sector, aiming to attract more investor interest in its business growth.
- Technology-Driven Healthcare Model: The company supports over 20,000 providers and 1.6 million patients through its AI-powered platform, driving value-based care arrangements that enhance patient experiences and outcomes.
- Physician-Centric Services: Astrana Health is committed to building a scalable care delivery infrastructure from the physician's perspective, ensuring high-quality, patient-centered care that enhances the overall value of the healthcare system.
- Vision for Future Development: The company's goal is to create a better healthcare system by integrating primary, specialty, and ancillary care, aiming for improved care, experiences, and outcomes while promoting sustainable industry growth.
See More
Astrana Health to Participate in Multiple Upcoming Investor Conferences
- Investor Conference Schedule: Astrana Health will participate in the TD Cowen 45th Annual Health Care Conference in Boston on March 4, 2026, featuring a fireside chat at 9:10am ET, showcasing the company's innovative capabilities in healthcare.
- Value-Based Summit: The company will also attend the Jefferies Value-Based Healthcare Summit in Miami on March 9, 2026, with a fireside chat at 11am ET, further emphasizing its leadership in value-based care.
- Global Healthcare Conference: Astrana will participate in the Barclays 28th Annual Global Healthcare Conference in Miami on March 10-11, 2026, with a fireside chat on March 11, providing investors with in-depth analysis of company strategy and market outlook.
- Virtual Forum Participation: Additionally, Astrana will engage in the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, and the Oppenheimer 36th Annual MedTech & Services Conference on March 18, 2026, demonstrating its ongoing innovation and market adaptability in the healthcare technology sector.
See More
U.S. Stocks Mixed as Fear Index Shows Slight Easing
- Fear Index Update: The CNN Money Fear & Greed Index registered at 41.6 on Monday, indicating a slight increase but remaining in the 'Fear' zone, which suggests continued cautious market sentiment that could exert downward pressure on stock prices.
- Mixed Market Performance: The Dow Jones fell approximately 73 points to close at 48,904.78, while the S&P 500 edged up 0.04% to 6,881.62, reflecting a divergence in sector performance, particularly with consumer staples and healthcare stocks facing significant losses.
- Manufacturing Data Decline: The ISM manufacturing PMI decreased from 52.6 to 52.4, although this was above market expectations of 51.8, indicating a moderate slowdown in manufacturing activity that may impact investor confidence moving forward.
- Middle East Tensions: President Trump defended 'Operation Epic Fury' during a White House briefing, aiming to dismantle Iran's military capabilities within a four to five-week timeline, yet the escalating tensions could heighten investor anxiety and market volatility.
See More
ASTH Stock 52-Week Highs and Lows Analysis
- Price Fluctuation Analysis: ASTH's 52-week low is $18.08 per share, while the high is $34.80, with the last trade at $25.27, indicating the stock's price volatility and reflecting market interest and investor sentiment changes.
- Market Trend Observation: The current price of $25.27 is close to the 52-week median, suggesting a potential recovery in investor confidence, particularly after significant fluctuations, which may attract more investor attention.
- Technical Indicator Reference: ASTH's stock price has crossed above its 200-day moving average, potentially signaling a short-term upward trend, prompting investors to monitor this technical signal for future investment opportunities.
- Investor Sentiment Assessment: Although the current stock price is below the 52-week high, it remains above the low, indicating market recognition of ASTH's potential value, leading investors to seek buying opportunities within this price range.
See More
Astrana Health to Participate in Upcoming Investor Conferences
- Investor Conference Participation: Astrana Health announced that its leadership will participate in upcoming investor conferences, aiming to enhance the company's visibility in the healthcare sector and attract potential investors, thereby driving future growth and development.
- Tech-Driven Healthcare Services: As a physician-centric, technology-enabled healthcare company, Astrana Health supports over 20,000 providers and 1.6 million patients through its proprietary technology platform and aligned provider networks, committed to delivering high-quality, value-based care that enhances patient experiences and outcomes.
- Scalable Care Infrastructure: By combining a scalable care delivery infrastructure, Astrana Health promotes the implementation of proactive and preventive care, aiming to improve patient outcomes and enhance provider well-being, thus creating greater value across the healthcare system.
- Patient-Centric Commitment: Astrana Health's mission is to build a better healthcare system that ensures all patients receive high-quality care through better experiences and outcomes, reflecting the company's strong commitment to patient-centered principles.
See More
Astrana Health to Participate in Upcoming Investor Conferences
- Investor Conference Schedule: Astrana Health is set to participate in the 25th Annual Needham Virtual Healthcare Conference from April 13-16, 2026, showcasing its innovations and technology in healthcare to attract investor interest.
- Global Healthcare Conference: The company will also attend the Bank of America Global Healthcare Conference in Las Vegas from May 12-14, 2026, with a fireside chat scheduled for May 12, aimed at enhancing its market visibility and investor confidence.
- Growth Stock Conference: Astrana will be present at the 46th Annual William Blair Growth Stock Conference in Chicago from June 2-4, 2026, featuring a fireside chat on June 3 to highlight its achievements and future vision in value-based care.
- Provider Network Expansion: Currently, Astrana Health supports over 20,000 providers and 1.6 million patients, focusing on delivering high-quality, patient-centered care through its unique technology platform and aligned provider networks, thereby improving patient experiences and outcomes.
See More
Astrana Health to Participate in Upcoming Investor Conferences
- Investor Conference Participation: Astrana Health is set to participate in upcoming investor conferences to showcase its innovations and technological capabilities in the healthcare sector, aiming to attract more investor interest in its business growth.
- Technology-Driven Healthcare Model: The company supports over 20,000 providers and 1.6 million patients through its AI-powered platform, driving value-based care arrangements that enhance patient experiences and outcomes.
- Physician-Centric Services: Astrana Health is committed to building a scalable care delivery infrastructure from the physician's perspective, ensuring high-quality, patient-centered care that enhances the overall value of the healthcare system.
- Vision for Future Development: The company's goal is to create a better healthcare system by integrating primary, specialty, and ancillary care, aiming for improved care, experiences, and outcomes while promoting sustainable industry growth.
See More
Astrana Health to Participate in Multiple Upcoming Investor Conferences
- Investor Conference Schedule: Astrana Health will participate in the TD Cowen 45th Annual Health Care Conference in Boston on March 4, 2026, featuring a fireside chat at 9:10am ET, showcasing the company's innovative capabilities in healthcare.
- Value-Based Summit: The company will also attend the Jefferies Value-Based Healthcare Summit in Miami on March 9, 2026, with a fireside chat at 11am ET, further emphasizing its leadership in value-based care.
- Global Healthcare Conference: Astrana will participate in the Barclays 28th Annual Global Healthcare Conference in Miami on March 10-11, 2026, with a fireside chat on March 11, providing investors with in-depth analysis of company strategy and market outlook.
- Virtual Forum Participation: Additionally, Astrana will engage in the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, and the Oppenheimer 36th Annual MedTech & Services Conference on March 18, 2026, demonstrating its ongoing innovation and market adaptability in the healthcare technology sector.
See More
U.S. Stocks Mixed as Fear Index Shows Slight Easing
- Fear Index Update: The CNN Money Fear & Greed Index registered at 41.6 on Monday, indicating a slight increase but remaining in the 'Fear' zone, which suggests continued cautious market sentiment that could exert downward pressure on stock prices.
- Mixed Market Performance: The Dow Jones fell approximately 73 points to close at 48,904.78, while the S&P 500 edged up 0.04% to 6,881.62, reflecting a divergence in sector performance, particularly with consumer staples and healthcare stocks facing significant losses.
- Manufacturing Data Decline: The ISM manufacturing PMI decreased from 52.6 to 52.4, although this was above market expectations of 51.8, indicating a moderate slowdown in manufacturing activity that may impact investor confidence moving forward.
- Middle East Tensions: President Trump defended 'Operation Epic Fury' during a White House briefing, aiming to dismantle Iran's military capabilities within a four to five-week timeline, yet the escalating tensions could heighten investor anxiety and market volatility.
See More
ASTH Stock 52-Week Highs and Lows Analysis
- Price Fluctuation Analysis: ASTH's 52-week low is $18.08 per share, while the high is $34.80, with the last trade at $25.27, indicating the stock's price volatility and reflecting market interest and investor sentiment changes.
- Market Trend Observation: The current price of $25.27 is close to the 52-week median, suggesting a potential recovery in investor confidence, particularly after significant fluctuations, which may attract more investor attention.
- Technical Indicator Reference: ASTH's stock price has crossed above its 200-day moving average, potentially signaling a short-term upward trend, prompting investors to monitor this technical signal for future investment opportunities.
- Investor Sentiment Assessment: Although the current stock price is below the 52-week high, it remains above the low, indicating market recognition of ASTH's potential value, leading investors to seek buying opportunities within this price range.
See More
